Augmented Depression Therapy (ADepT) Case Series

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Ohio State University
Study ID
NCT07733310
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Depression / Major Depressive Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Augmented Depression Therapy (ADepT) — BEHAVIORAL
    ADepT is a solution-focused behavioral health intervention that blends techniques from cognitive, behavioral, and acceptance-based treatments to help patients manage symptoms of depression and increase wellbeing. It consists of 15 acute treatment sessions and up to 5 booster sessions.

Study Details

This research study plans to examine the use of Augmented Depression Therapy (ADepT) in order to evaluate what patients think about ADepT and how well it works. ADepT is a type of therapy that builds wellbeing and is being provided to you as standard of care. ADepT treatment consists of 15 therapy sessions (typically provided weekly) with each session lasting around 60 minutes. Following these sessions, you can receive five optional booster sessions over the next 12 months with each of these lasting around 60 minutes. Ultimately, the timing and duration of these sessions will be determined between you and your provider and scheduled accordingly. As part of this study you will be randomized (randomly assigned) to different research assessment lengths before the start of treatment and then will complete assessments for the 12 months following the end of the weekly portion of ADepT treatment. The length of your participation will be between 70 weeks to 82 weeks.

Key Dates

First listed
Jul 29, 2026
Start date
Aug 1, 2026
Status verified
Jul 2026
Primary completion
Aug 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: 3 week baseline + ADepT
    Baseline assessments will be made weekly for 3 weeks, followed by a standard course of ADepT.
  • Experimental: 4 week baseline + ADepT
    Baseline assessments will be made weekly for 4 weeks, followed by a standard course of ADepT.
  • Experimental: 5 week baseline + ADepT
    Baseline assessments will be made weekly for 5 weeks, followed by a standard course of ADepT.
  • Experimental: 6 week baseline + ADepT
    Baseline assessments will be made weekly for 6 weeks, followed by a standard course of ADepT.
  • Experimental: 7 week baseline + ADepT
    Baseline assessments will be made weekly for 7 weeks, followed by a standard course of ADepT.
  • Experimental: 8 week baseline + ADepT
    Baseline assessments will be made weekly for 8 weeks, followed by a standard course of ADepT.

Primary Outcome Measure

Acceptability [ Time Frame: From enrollment to the end of treatment at 82 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The Ohio State University Wexner Medical CenterColumbusOhio43214
Jay Fournier, PhD
[email protected]
614-814-6485

Find similar trials in Columbus, OH

By research site
The Ohio State University Wexner Medical Center· Columbus, OH

Related Studies